Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

A Study to Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms.

← catalyst calendar

NCT05879718 · results posted

Sponsored by Pfizer (industry) · PFE — their whole pipeline →.

Phase
Phase 2
Status
Terminated
Study type
Interventional
Design
Randomized · Triple · Treatment
Enrollment
8actual
Sites
19
Countries
Canada, Greece, Spain +1

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Why the sponsor stopped it

Pfizer has made an internal business decision to not continue this study. This decision was not due to safety concerns or clinical effect reasons or requests from any regulatory authorities.

As filed on the registry record, in the sponsor's own words.

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2023-07-07actualWhen the study began enrolling
Primary completion2025-06-05actualThe date the last participant is measured for the primary outcome — the readout window
Study completion2025-11-18actualThe whole study's end, after follow-up
First posted2023-05-30actualWhen this record first appeared on the registry
Results posted2026-08-11actualWhen the sponsor posted results to the registry
Record updated2026-08-11actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Conditions

  • Lupus Erythematosus, Systemic
  • Lupus Erythematosus, Cutaneous

Interventions

  • Drug: Placebo
  • Drug: PF-06823859

Primary outcome

what the primary-completion date above is the date OF
Change From Baseline in Type 1 Interferon (IFN) Gene Signature (GS) Score in Lesional Skin at Week 12
measured Baseline, Week 12

Posted documents

hosted by the registry — we link, never re-serve
Study Protocolposted 2023-10-26 · 27.3 MB · Prot_000.pdf
Statistical Analysis Planposted 2025-11-25 · 3.0 MB · SAP_001.pdf

Permalink · PFE's whole pipeline · Catalyst calendar · Every registered study · What changed